The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy

J.A.E.M. Zecha, J.E. Raber-Durlacher, A.M.G.A. Laheij, J.B. Epstein, J. de Lange, L.E. Smeele

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening infectious complications and should therefore be considered a medical emergency. Patients presenting with FN are routinely subjected to careful history taking and physical examination including X-rays and microbiological evaluations. Nevertheless, an infection is documented clinically in only 20–30% of cases, whereas a causative microbial pathogen is not identified in over 70% of FN cases. The oral cavity is generally only visually inspected. Although it is recognized that ulcerative oral mucositis may be involved in the development of FN, the contribution of infections of the periodontium, the dentition, and salivary glands may be underestimated. These infections can be easily overlooked, as symptoms and signs of inflammation may be limited or absent during neutropenia. This narrative review is aimed to inform the clinician on the potential role of the oral cavity as a potential source in the development of FN. Areas for future research directed to advancing optimal management strategies are discussed.
Original languageEnglish
Pages (from-to)3667-3679
JournalSupportive Care in Cancer
Volume27
Issue number10
DOIs
Publication statusPublished - Oct 2019

Funding

Acknowledgements We kindly acknowledge support from the Eklund Foundation.

FundersFunder number
Eklund Foundation

    Fingerprint

    Dive into the research topics of 'The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy'. Together they form a unique fingerprint.

    Cite this